methyl 3-{[2-(piperidin-1-yl)ethyl]amino}butanoate, 95.0%, 10g

2-Vinylbenzoic acid, stabilized with 10ppm TBC, 95% mix TBC as stabilizer, 5g

1-Azabicyclo[2.2.2]octane-4-carboxylic acid, 95%, 1g

2-Methylpropan-2-amine hydrochloride, 95%, 100g

4-chloro-N,N-dimethyl-3-nitrobenzamide, 95.0%, 1g

1-Methyl-4-nitro-1H-pyrazole-3-carboxylic acid, 95.0%, 10g

Citric acid solution, min. 46%, ultra pure, 25 l, plastic packaging.

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid, 98.0%, 5g

2-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 5g

(S)-2-((tert-Butoxycarbonyl)amino)-3,3-dicyclopropylpropanoic acid, 98%, 250mg

LACIDIPINE, 98%, 25g

2,4-Bis((dodecylthio)methyl)-6-methylphenol, 97%, 25g

2-fluoro-3'-piperidinomethyl benzophenone, 97.0%, 1g